Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (7)

2014

  1. Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study

    Arthritis Research and Therapy, Vol. 16, Núm. 1

2013

  1. Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico

    Reumatologia Clinica, Vol. 9, Núm. 5, pp. 281-296

2009

  1. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility

    Arthritis Research and Therapy, Vol. 11, Núm. 2

2006

  1. SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis

    Journal of Rheumatology, Vol. 33, Núm. 6, pp. 1048-1051

2005

  1. Polymorphism of the interleukin-1 receptor antagonist gene: A factor in susceptibility to rheumatoid arthritis in a Spanish population

    Arthritis and Rheumatism, Vol. 52, Núm. 10, pp. 3015-3019

2003

  1. CARD15/NOD2 analysis in rheumatoid arthritis susceptibility

    Rheumatology, Vol. 42, Núm. 11, pp. 1380-1382

1998

  1. Cyclooxygenase (COX) 1 and 2 are expressed by T cells.

    ARTHRITIS AND RHEUMATISM